Apella Capital’s Zoetis ZTS Stock Holding History

Apella Capital’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,763	Closed	-$332K	–	234
2022 Q1	$332K	Buy	1,763 +363	+26%	+$71.8K	0.05%	159
2021 Q4	$342K	Buy	+1,400	New	+$307K	0.04%	152

Other funds holding ZTS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Apella Capital's ZTS Position: Q2 2022 in Review

Apella Capital sold out of Zoetis (ZTS) in Q2 2022, closing a stake of 1,763 shares — an estimated $332K sold.

Apella Capital first reported a position in ZTS in Q4 2021 and held it in 2 quarters. The position peaked at $342K in Q4 2021. 1,563 funds tracked by Wall St. Rank hold ZTS as of Q2 2022.

Apella Capital reported no remaining Zoetis position as of Q2 2022 after selling out during the quarter.
Apella Capital sold 1,763 Zoetis shares in Q2 2022, an estimated $332K.
Apella Capital first reported a position in Zoetis in Q4 2021 and held it in 2 quarters.
Apella Capital's Zoetis position peaked at $342K in Q4 2021.
1,563 funds tracked by Wall St. Rank held Zoetis as of Q2 2022.

Based on Apella Capital's 13F filing for Q2 2022, filed 8 Jul 2022.